TNFRSF1A and diabetic kidney disease: Despite these limitations, our multi-omics approach—including single-cell transcriptomics, spatial biology, causal genetics, and cross-species validation—provided support for TNFRSF1A as an important mediator of immune microenvironment reprogramming in DKD and a promising therapeutic target.